CH531492A - Antiinflammatory pregnene-diones - Google Patents

Antiinflammatory pregnene-diones

Info

Publication number
CH531492A
CH531492A CH860272A CH860272A CH531492A CH 531492 A CH531492 A CH 531492A CH 860272 A CH860272 A CH 860272A CH 860272 A CH860272 A CH 860272A CH 531492 A CH531492 A CH 531492A
Authority
CH
Switzerland
Prior art keywords
beta
pregnene
acid
methylene
dione
Prior art date
Application number
CH860272A
Other languages
German (de)
Inventor
Andor Fuerst
Marcel Mueller
Peter Mueller
Arno Johannes Schocher
Elisabeth Becher
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to CH860272A priority Critical patent/CH531492A/en
Publication of CH531492A publication Critical patent/CH531492A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01DMEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D9/00Recording measured values
    • G01D9/28Producing one or more recordings, each recording being of the values of two or more different variables
    • G01D9/30Producing one or more recordings, each recording being of the values of two or more different variables there being a separate recording element for each variable, e.g. multiple-pen recorder
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01DMEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D18/00Testing or calibrating apparatus or arrangements provided for in groups G01D1/00 - G01D15/00
    • GPHYSICS
    • G07CHECKING-DEVICES
    • G07CTIME OR ATTENDANCE REGISTERS; REGISTERING OR INDICATING THE WORKING OF MACHINES; GENERATING RANDOM NUMBERS; VOTING OR LOTTERY APPARATUS; ARRANGEMENTS, SYSTEMS OR APPARATUS FOR CHECKING NOT PROVIDED FOR ELSEWHERE
    • G07C3/00Registering or indicating the condition or the working of machines or other apparatus, other than vehicles
    • G07C3/08Registering or indicating the production of the machine either with or without registering working or idle time
    • G07C3/12Registering or indicating the production of the machine either with or without registering working or idle time in graphical form
    • GPHYSICS
    • G08SIGNALLING
    • G08GTRAFFIC CONTROL SYSTEMS
    • G08G1/00Traffic control systems for road vehicles
    • G08G1/01Detecting movement of traffic to be counted or controlled

Landscapes

  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Trihydroxypregnene-3,20-diones (I) and especially 11 beta, 17 alpha, 21-trihydroxy-15, 16 beta-methylene-pregnene (4)-(and pregna-1,4-diene)-3,20-dione, for use as anti-inflammatories. R6 and R9 independently are H, halogen, R17, R21 independently are OH or O-acyl; Z is CO or beta-CH2OH. Preparation of (I) and 1,2-dehydro-deriv. by numerous methods e.g. (a) microbiological 11-hydroxylation of (I) (Z=CH2); (b) 1,2-dehydrogenation of a cmpd. (I); (c) adding HOCl or HOBr to the 9,11-double bond a cmpd. (I) or its, 1,2-dehydro-derivs. (Z = HC). In an example 11 beta, 17 alpha-21-trihydroxy-15,16 beta-methylene-pregnene (4)-3,20-dione, m.p. 219-221 degrees is obtained by microbiological hydroxylation of 17 alpha, 21-dihydroxy-15,16 beta-methylene-pregnene (4)-3,20-dione using Coniothyrium hellebori as organism.

Description

       

  
 



  Verfahren zur Herstellung neuer Steroide der Pregnanreihe
Die Erfindung betrifft ein Verfahren zur Herstellung neuer Steroide der Formel
EMI1.1     
 in der R6 und   Rg    unabhängig voneinander Wasserstoff, Fluor, Chlor oder Brom, R21 Hydroxy oder Acyloxy und Z Carbonyl oder ss-Hydroxymethylen bedeuten bzw. deren 1,2 Dehydroderivate.



   Eine Acyloxygruppe enthält vorzugsweise den Rest einer gesättigten oder ungesättigten aliphatischen oder cycloaliphatischen, einer araliphatischen oder aromatischen Carbonsäure mit bis zu 20, vorzugsweise bis zu 12 C-Atomen. Beispiele solcher Säuren sind Ameisensäure, Essigsäure, Pivalinsäure, Propionsäure, Buttersäure, Capronsäure, Önanthsäure, Ölsäure, Palmitinsäure, Stearinsäure, Bernsteinsäure, Malonsäure, Fumarsäure, Zintronensäure, Cyclohexylpropionsäure, Phenylessigsäure und Benzoesäure.



   Bevorzugte erfindungsgemäss erhältliche Verbindungen sind diejenigen, in denen R6 und R9 Wasserstoff oder Fluor,   R21    Hydroxy und Z   ,B-Hydroxymethylen    darstellen.



   Das erfindungsgemässe Verfahren ist dadurch gekennzeichnet, dass man ein Steroid der Formel
EMI1.2     
 worin R6, R9 und Z die obige Bedeutung besitzen und Ac einen Acylrest darstellt, oder das 1,2-Dehydroderivat eines solchen Steroids mindestens in der Stellung 17a verseift.



   Zur Herstellung der Ausgangsstoffe kann auf die belgische Patentschrift Nr. 760 392 verwiesen werden.



   Die erfindungsgemäss erhältlichen Steroide sind endocrin, insbesondere antiinflammatorisch, wirksam. Sie können als Heilmittel in Form pharmazeutischer Präparate Verwendung finden, welche sie in Mischung mit einem für die enterale, perkutane oder parenterale Applikation geeigneten pharmazeutischen, organischen oder anorganischen inerten Trägermaterial enthalten. Die pharmazeutischen Präparate können in fester Form, in halbfester oder in flüssiger Form vorliegen. Gegebenenfalls enthalten sie Hilfsstoffe, wie Konservierungs-, Stabilisierungs-, Netz- oder Emulgiermittel, Salze zur Veränderung des osmotischen Druckes oder Puffer.



  Sie können auch noch andere therapeutisch wertvolle Stoffe enthalten.



   Beispiel 1
300 mg   17a,21-Diacetoxy-l l-hydroxy-15ss,16P-methy-    len-pregn-4-en-3,20-dion wurden in 30 ml Methanol gelöst und mit 150 mg NaHCO3 6 Stunden bei Raumtemperatur  gerührt. Zur Aufarbeitung wurde auf Eiswasser gegossen und mit Methylenchlorid extrahiert. Der organische Extrakt wurde mit Wasser neutral gewaschen, mit Na2SO4 getrocknet und im Vakuum eingedampft. Der Rückstand wurde auf 30 g Silicagel chromatographiert. Mit Benzol-Propanol   (95 :5)    wurde zunächst reines   2 1-Acetoxy- 11ss, 17a-dihydroxy-      lSss,16ss-methylen-pregn-4-en-3,20-dion    eluiert. Die nachfolgenden Fraktionen lieferten   llss,17a,21-Trihydroxy-    15ss,16ss-methylen-pregn-4-en-3,20-dion, Smp.   218-220" C.   

 

   Beispiel 2
921 mg   21-Acetoxy-17-hydroxy-lSss,16ss-methylen-pregn-    4-en-3,11,20-trion und 46 mg Kaliumcarbonat wurden in 25 ml Methanol gelöst und 2 Stunden bei Raumtemperatur gerührt. Zur Aufarbeitung goss man auf Eiswasser und extrahierte mit Methylenchlorid. Durch Neutralwaschen mit Wasser, Trocknen mit Na2SO4 und Eindampfen des Lösungsmittels im Vakuum wurden aus dem organischen Extrakt 863 mg Rohprodukt erhalten. Dieses wurde auf Silicagel chromatographiert. Mit Benzol-Propanol (9: 1) wurde reines   17,21-Dihydroxy-lSss,16ss-methylen-pregn-4-en-3,11,20-trion    isoliert. Schmelzpunkt   217O    (Zers.).   [a]D25 =      + 180       (c=0,1    in Dioxan). 



  
 



  Process for the production of new steroids of the Pregnan range
The invention relates to a process for the preparation of new steroids of the formula
EMI1.1
 in which R6 and Rg independently of one another are hydrogen, fluorine, chlorine or bromine, R21 is hydroxy or acyloxy and Z is carbonyl or ß-hydroxymethylene or 1,2 dehydro derivatives thereof.



   An acyloxy group preferably contains the residue of a saturated or unsaturated aliphatic or cycloaliphatic, an araliphatic or aromatic carboxylic acid having up to 20, preferably up to 12, carbon atoms. Examples of such acids are formic acid, acetic acid, pivalic acid, propionic acid, butyric acid, caproic acid, enanthic acid, oleic acid, palmitic acid, stearic acid, succinic acid, malonic acid, fumaric acid, tintronic acid, cyclohexylpropionic acid, phenylacetic acid and benzoic acid.



   Preferred compounds obtainable according to the invention are those in which R6 and R9 are hydrogen or fluorine, R21 is hydroxy and Z, B-hydroxymethylene.



   The method according to the invention is characterized in that a steroid of the formula
EMI1.2
 where R6, R9 and Z have the above meaning and Ac is an acyl radical, or the 1,2-dehydro derivative of such a steroid is saponified at least in the 17a position.



   For the preparation of the starting materials, reference can be made to Belgian patent specification No. 760 392.



   The steroids obtainable according to the invention are endocrine, in particular anti-inflammatory, effective. They can be used as remedies in the form of pharmaceutical preparations which they contain as a mixture with a pharmaceutical, organic or inorganic inert carrier material suitable for enteral, percutaneous or parenteral administration. The pharmaceutical preparations can be in solid, semi-solid or liquid form. They may contain auxiliaries, such as preservatives, stabilizers, wetting agents or emulsifiers, salts to change the osmotic pressure or buffers.



  They can also contain other therapeutically valuable substances.



   example 1
300 mg of 17a, 21-diacetoxy-11-hydroxy-15ss, 16P-methylene-pregn-4-en-3,20-dione were dissolved in 30 ml of methanol and stirred with 150 mg of NaHCO3 for 6 hours at room temperature. For work-up, it was poured onto ice-water and extracted with methylene chloride. The organic extract was washed neutral with water, dried with Na2SO4 and evaporated in vacuo. The residue was chromatographed on 30 g of silica gel. With benzene-propanol (95: 5), pure 2 1-acetoxy-11ss, 17a-dihydroxy-lSss, 16ss-methylen-pregn-4-en-3,20-dione was first eluted. The following fractions yielded 11ss, 17a, 21-trihydroxy-15ss, 16ss-methylen-pregn-4-en-3,20-dione, m.p. 218-220 "C.

 

   Example 2
921 mg of 21-acetoxy-17-hydroxy-lSss, 16ss-methylene-pregn-4-en-3,11,20-trione and 46 mg of potassium carbonate were dissolved in 25 ml of methanol and stirred for 2 hours at room temperature. For work-up, it was poured into ice water and extracted with methylene chloride. By washing neutral with water, drying with Na2SO4 and evaporating the solvent in vacuo, 863 mg of crude product were obtained from the organic extract. This was chromatographed on silica gel. With benzene-propanol (9: 1), pure 17,21-dihydroxy-lSss, 16ss-methylene-pregn-4-ene-3,11,20-trione was isolated. Melting point 2170 (dec.). [a] D25 = +180 (c = 0.1 in dioxane).


    

Claims (1)

PATENTANSPRUCH PATENT CLAIM Verfahren zur Herstellung neuer Steroide der Formel EMI2.1 in der R6 und Rg unabhängig voneinander Wasserstoff, Fluor, Chlor oder Brom, R21 Hydroxy oder Acyloxy und Z Carbonyl oder ss-Hydroxymethylen bedeuten, bzw. deren 1,2 Dehydroderivate, dadurch gekennzeichnet, dass man eine Verbindung der Formel EMI2.2 worin Ac einen Acylrest darstellt, oder ein entsprechendes 1,2-Dehydroderivat davon mindestens in der Stellung 17a verseift. Process for making new steroids of the formula EMI2.1 in which R6 and Rg are independently hydrogen, fluorine, chlorine or bromine, R21 is hydroxy or acyloxy and Z is carbonyl or β-hydroxymethylene, or 1,2 dehydro derivatives thereof, characterized in that a compound of the formula EMI2.2 wherein Ac is an acyl radical, or a corresponding 1,2-dehydroderivative thereof saponified at least in the 17a position. UNTERANSPRUCH Verfahren nach Patentanspruch, dadurch gekennzeichnet, dass man von Verbindungen ausgeht, in denen R6 und Rg Wasserstoff oder Fluor und Z ss-Hydroxymethylen darstellen. SUBClaim Process according to claim, characterized in that one starts out from compounds in which R6 and Rg represent hydrogen or fluorine and Z is ss-hydroxymethylene.
CH860272A 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones CH531492A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CH860272A CH531492A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH860272A CH531492A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones
CH1883169A CH525872A (en) 1969-12-17 1969-12-17 Process for the production of new steroids of the Pregnan range

Publications (1)

Publication Number Publication Date
CH531492A true CH531492A (en) 1972-12-15

Family

ID=4435537

Family Applications (11)

Application Number Title Priority Date Filing Date
CH860072A CH531491A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones
CH860672A CH531486A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones
CH860372A CH531493A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones
CH859972A CH531490A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones
CH859772A CH531485A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones
CH860472A CH531494A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones
CH860172A CH531487A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones
CH1883169A CH525872A (en) 1969-12-17 1969-12-17 Process for the production of new steroids of the Pregnan range
CH860272A CH531492A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones
CH859872A CH529734A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones
CH860572A CH531495A (en) 1969-12-17 1970-10-30 Antiinflammatory pregnene-diones

Family Applications Before (8)

Application Number Title Priority Date Filing Date
CH860072A CH531491A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones
CH860672A CH531486A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones
CH860372A CH531493A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones
CH859972A CH531490A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones
CH859772A CH531485A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones
CH860472A CH531494A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones
CH860172A CH531487A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones
CH1883169A CH525872A (en) 1969-12-17 1969-12-17 Process for the production of new steroids of the Pregnan range

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH859872A CH529734A (en) 1969-12-17 1969-12-17 Antiinflammatory pregnene-diones
CH860572A CH531495A (en) 1969-12-17 1970-10-30 Antiinflammatory pregnene-diones

Country Status (17)

Country Link
JP (1) JPS4920774B1 (en)
AT (8) AT315397B (en)
BE (1) BE760392A (en)
CA (1) CA955931A (en)
CH (11) CH531491A (en)
DE (1) DE2061183C3 (en)
ES (2) ES386503A1 (en)
FI (1) FI47484C (en)
FR (1) FR2081369B1 (en)
GB (1) GB1276419A (en)
HU (1) HU162802B (en)
IE (1) IE34816B1 (en)
IL (1) IL35790A (en)
NL (1) NL7016761A (en)
NO (1) NO135528C (en)
YU (1) YU34700B (en)
ZA (1) ZA708096B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2740344A (en) * 1951-12-05 1956-04-03 Messrs Lumoprint Zindler K G Device for treating directly exposed photopapers
DE2453823C2 (en) * 1974-11-11 1984-08-09 Schering AG, 1000 Berlin und 4709 Bergkamen 11β, 17α-dihydroxy-15α, 16α-methylene-1,4-pregnadiene-3,20-dione
JPS56109115A (en) * 1980-12-05 1981-08-29 Fukui Kikai Kk Controlling method for feeder for strip material

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3438975A (en) * 1966-07-01 1969-04-15 Syntex Corp 15alpha,16alpha-methylene pregnanes and 19-nor-pregnanes
CH503712A (en) * 1968-04-22 1971-02-28 Hoffmann La Roche Hormone active steroids

Also Published As

Publication number Publication date
GB1276419A (en) 1972-06-01
FI47484B (en) 1973-08-31
AT315397B (en) 1974-05-27
NL7016761A (en) 1971-06-21
AT316771B (en) 1974-07-25
CH531491A (en) 1972-12-15
AT316773B (en) 1974-07-25
NO135528C (en) 1977-04-20
FR2081369A1 (en) 1971-12-03
BE760392A (en) 1971-06-16
FI47484C (en) 1973-12-10
IE34816B1 (en) 1975-08-20
IL35790A0 (en) 1971-02-25
JPS4920774B1 (en) 1974-05-27
DE2061183A1 (en) 1971-06-24
ES386503A1 (en) 1973-03-16
ES403723A2 (en) 1975-05-01
DE2061183B2 (en) 1979-05-23
CA955931A (en) 1974-10-08
DE2061183C3 (en) 1980-01-17
YU34700B (en) 1979-12-31
AT308292B (en) 1973-06-25
CH525872A (en) 1972-07-31
AT316774B (en) 1974-07-25
FR2081369B1 (en) 1975-04-18
AT316772B (en) 1974-07-25
CH531490A (en) 1972-12-15
CH531493A (en) 1972-12-15
ZA708096B (en) 1971-09-29
CH531487A (en) 1972-12-15
AT315395B (en) 1974-05-27
CH531485A (en) 1972-12-15
AT315396B (en) 1974-05-27
CH531495A (en) 1972-12-15
NO135528B (en) 1977-01-10
CH529734A (en) 1972-10-31
CH531494A (en) 1972-12-15
IL35790A (en) 1974-05-16
IE34816L (en) 1971-06-17
HU162802B (en) 1973-04-28
YU298070A (en) 1979-07-10
CH531486A (en) 1972-12-15

Similar Documents

Publication Publication Date Title
DE2314592C2 (en) D-homo-steroids, process for their production and preparations containing them
CH531492A (en) Antiinflammatory pregnene-diones
CH625809A5 (en) Process for the preparation of polyhalogenated steroids
CH505080A (en) Hormone active steroids
DE1250821B (en) Process for the preparation of 17a-hydroxy-3-keto- / 14-pregnen-17-acylates
DE2144405A1 (en) Saponification of pregnane series esters - using silica gel
AT361644B (en) METHOD FOR PRODUCING NEW D-HOMOSTEROIDS
DE1618936C3 (en) Process for the preparation of fluorine compounds of the pregnancy series. Eliminated from: 1418394 Anmr Syntex S.A., Mexico City
CH508611A (en) Process for the 17a-alkylation of 20-keto steroids of the pregnane series
DE1493313C (en) 16b, 17 cycloenol ethers of 17alpha hydroxy öalpha methyl 3.20 dioxo 4 pregnen 16alpha acetaldehyde and des 1 lbeta, 17alpha dihydroxy 9alpha fluorine 6alpha methyl 3.20 dioxo 1,4 pregnadiene 16alpha acetaldehyde and process for their preparation
AT236040B (en) Process for the preparation of 3-hydroxy-9 (11), 16-pregnadien-20-one, 3, 11Β-dihydroxy-16-pregnen-20-one and C-3 esters of these compounds
AT369388B (en) METHOD FOR PRODUCING NEW D-HOMOSTEROIDS
AT231618B (en) Process for the preparation of 1, 4, 9 (11) -unsaturated compounds of the pregnane series
DE1113453B (en) Process for the production of substitution products of Reichsteins-Substance-S or their 21-acylates
CH499505A (en) Steroids of the partial formula (I):- where R1 is halogen (at wt.100) or alkyl Q is oxo or 1,2-alkylenedioxy (2-4C) M is the remainder of the
CH606115A5 (en) 9-Alpha-11-beta-dihalo-D-homo-pregn-4-en-3,20-diones
CH527808A (en) 9beta 10alpha-steroids progestatives
CH553759A (en) PROCESS FOR THE PREPARATION OF NEW 4-CHLORO-1,2 (ALPHA) -METHYLENE (DELTA) 4,6-PREGNADIEN-17 (ALPHA) -OL-3,20-Dione, OR ITS 17ESTER.
DE1443176A1 (en) 6 alpha-fluoro-16-beta-methyl-4-pregnene and -1,4-pregnadienes and process for their preparation
CH606114A5 (en) 9-Alpha-11-beta-dihalo-D-homo-pregn-4-en-3,20-diones
CH330672A (en) Method of making steroids
CH507925A (en) 19-alkyl steroids
CH623339A5 (en) Process for the preparation of D-homosteroids
DE1048915B (en) Process for the preparation of 6-methyl-9ª ‡, 21-difluoro-11ª ‰, 17ª ‡ -dioxy-1,4-pregnadiene-3,20-dione and its 11-keto analogues
CH571022A5 (en) D-homo-corticosteroids - anti-inflammatories

Legal Events

Date Code Title Description
PL Patent ceased